Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Blumer

Showing results (61-70 of 163) with videos related to

Pageof 17
Sort By:
Clinical Pharmacokinetics|April 1, 1988
Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I)J B Besunder, M D Reed, J L Blumer
Critical Care Medicine|March 1, 1997
Colonization with antibiotic-resistant gram-negative organisms in a pediatric intensive care unitP Toltzis, T Yamashita, L Vilt, et al.
Journal of Clinical Pharmacology|July 1, 1995
Pharmacokinetic-based ticarcillin/clavulanic acid dose recommendations for infants and childrenM D Reed, T S Yamashita, J L Blumer
Drug Safety|March 10, 2001
Safety of antihistamines in childrenA P Ten Eick, J L Blumer, M D Reed
The Pediatric Infectious Disease Journal|January 1, 1987
Changing therapy for skin and soft tissue infections in children: have we come full circle?J L Blumer, E Lemon, J O'Horo, et al.
Pediatric Infectious Disease|May 1, 1985
Skin and soft tissue infections: pharmacologic approachesJ L Blumer, C A O'Brien, E Lemon, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1988
Randomized clinical trial of topical mupirocin versus oral erythromycin for impetigoJ Goldfarb, D Crenshaw, J O'Horo, et al.
Journal of Pediatric Psychology|February 1, 1992
Assessing distress in pediatric intensive care environments: the COMFORT scaleB Ambuel, K W Hamlett, C M Marx, et al.
Journal of Clinical Pharmacology|March 10, 2000
Acute encephalopathy due to aluminum toxicity successfully treated by combined intravenous deferoxamine and hemodialysisH Nakamura, P G Rose, J L Blumer, et al.
Cancer Research|June 1, 1981
Effect of genotype on mutagenicity of niridazole in nitroreductase-deficient bacteriaW T Speck, J L Blumer, E J Rosenkranz, et al.
Pageof 17

Showing results (61-70 of 163) with videos related to

Sort By:
Pageof 17
Clinical Pharmacokinetics|April 1, 1988
Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I)J B Besunder, M D Reed, J L Blumer
Critical Care Medicine|March 1, 1997
Colonization with antibiotic-resistant gram-negative organisms in a pediatric intensive care unitP Toltzis, T Yamashita, L Vilt, et al.
Journal of Clinical Pharmacology|July 1, 1995
Pharmacokinetic-based ticarcillin/clavulanic acid dose recommendations for infants and childrenM D Reed, T S Yamashita, J L Blumer
Drug Safety|March 10, 2001
Safety of antihistamines in childrenA P Ten Eick, J L Blumer, M D Reed
The Pediatric Infectious Disease Journal|January 1, 1987
Changing therapy for skin and soft tissue infections in children: have we come full circle?J L Blumer, E Lemon, J O'Horo, et al.
Pediatric Infectious Disease|May 1, 1985
Skin and soft tissue infections: pharmacologic approachesJ L Blumer, C A O'Brien, E Lemon, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1988
Randomized clinical trial of topical mupirocin versus oral erythromycin for impetigoJ Goldfarb, D Crenshaw, J O'Horo, et al.
Journal of Pediatric Psychology|February 1, 1992
Assessing distress in pediatric intensive care environments: the COMFORT scaleB Ambuel, K W Hamlett, C M Marx, et al.
Journal of Clinical Pharmacology|March 10, 2000
Acute encephalopathy due to aluminum toxicity successfully treated by combined intravenous deferoxamine and hemodialysisH Nakamura, P G Rose, J L Blumer, et al.
Cancer Research|June 1, 1981
Effect of genotype on mutagenicity of niridazole in nitroreductase-deficient bacteriaW T Speck, J L Blumer, E J Rosenkranz, et al.
Pageof 17